The HIV virus’s capacity to defy the immune system of the human body is a subject that scientists all over the world have been working on for quiet some time now. However, a researcher from the Indiana University has now found the compound that could possibly help the immune system fight diseases and viruses trying to enter the body. Although, it cannot be said with absolute certainty that the immune system fails to recognize all HIV viruses, yet a certain infection makes the body release antibodies to attack the virus. Keeping such considerations in mind, the study is currently trying to detect the compound that may check the virus’s power to shatter the protection mechanism of the immune system.

Via: http://www.sciencedaily.com/releases/2012/02/120213133704.htm

Gonorrhea is fast emerging into a scourge antibiotic resistant and without necessary action, the disease might take the shape of a serious public health threat, says a latest research. Gonorrhea, one of the most common STDs around, is responsible for causing diseases like urethritis and pelvic inflammatory diseases. It is fast turning into multi-resistant bacteria since a majority of the therapies for treating gonorrhea are now ineffective. Japan was the first nation to report a case of multi-resistant gonorrhea. The organism responsible for the condition, Neisseria gonorrhea, mutates rapidly and comes with a complex biology: a major reason why doctors have not been able to develop a vaccine, the study further reports. The study was conducted by Dr. Magnus Unemo and colleagues.

Via: http://www.sciencedaily.com/releases/2011/09/110919121806.htm

Northwestern medicine researchers have now struck upon a unique phenomenon. Their study sheds light on the first reported case of a genetic transfer between human cells and bacterial cells. The team has discovered a fragment of human DNA in a bacterial genome. In this case Neisseria gonorrhoeae, the gonorrhea causing bacterium, is the one to carry the human DNA fragment. Further study revealed that gene transfer is a latest revolutionary event. The findings offer a deep insight into the evolutionary process as well as the ability of STDs like gonorrhea to continually survive and adapt in human hosts. Gonorrhea, a disease transmitted through sexual encounters, is one of the oldest diseases known to human race.

Via: http://www.sciencedaily.com/releases/2011/02/110213174143.htm

Children and adolescents affected by STDs like HIV infection may benefit from the FDA approved antiviral drug raltegravir, says a latest study. The drug works by slowing the spread of HIV infection and is, therefore, being seen as a unique weapon for treating the STD. The claims have been made by a professor of pediatrics at the Stony Brook University. The clinical trial involved 96 patients who have all been treated with a regimen of HIV infections other than raltegravir. After undergoing treatment for several weeks with raltegravir, fifty-three percent of the patients had a negligible number of HIV viruses present in their blood streams.

Via: http://www.sciencedaily.com/releases/2012/01/120106135846.htm

Researchers have now identified fragments of protein in semen that fuel the HIV virus’s ability to get new cells infected. The path breaking discovery promises to curb the spread of this dangerous pathogen globally. The findings may help efforts to slow the growth of STDs like AIDS. Recent prevention methods focus primarily on microbicides, a chemical gel which when used by females during sexual encounters, blocks HIV infections. According to Dr. Roan, a member of the research group, their experiments suggest that certain fibrils derived majorly from semenogelins enhance HIV infection in the semen. The researchers are, however, intrigued by their biological and natural functions as well.

Via: http://www.sciencedaily.com/releases/2011/12/111214125850.htm